Effect of sucralfate and basic fibroblast growth factor on fibrovascular ingrowth into hydroxyapatite and porous polyethylene alloplastic implants using a novel rabbit model

Ophthalmic Plastic and Reconstructive Surgery

Volumn 13, Issue 1, 1997, Pages 8-17

  Rubin, Peter A D ^a,b   Nicaeus, Thilo E ^a   Warner, Michael A ^a   Remulla, Heidi D ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b MASSACHUSETTS EYE AND EAR INFIRMARY   (United States)

Author keywords

Angiogenesis; Basic fibroblast growth factor; Fibrovascular ingrowth; Hydroxyapatite (HA); Porous polyethylene (PP); Sucralfate

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; HYDROXYAPATITE; POLYETHYLENE; POLYMACON; SUCRALFATE;

ABDOMINAL WALL MUSCULATURE; ALLOGRAFT; ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL PROLIFERATION; FEMALE; IMPLANTATION; NONHUMAN; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RABBIT; SURGICAL TECHNIQUE; WOUND HEALING;

EID: 0030893865     PISSN: 07409303     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002341-199703000-00002     Document Type: Article

References (41)

1. Rubin PAD, Popham JK, Bilyk JR, Shore JW. Comparison of fibrovascular ingrowth into hydroxyapatite and porous polyethylene orbital implants. Ophthalmic Plast Reconstr Surg 1994;10:96-103.
2. Rubin PAD, Bilyk JR, Shore JW. Orbital reconstruction using porous polyethylene sheets. Ophthalmology 1994; 101:1697-708.
3. Merritt K, Shafer JW, Brown SA. Implant site infection rates with porous and dense materials. J Biomed Mater Res 1979;13:101-8.
4. Rosen HM. The response of porous hydroxyapatite to contiguous tissue infection. Plast Reconstr Surg 1991;88: 1076-80.
5. Berghaus A. Porous polyethylene in reconstructive head and neck surgery. Arch Otolaryngol 1985;111:154-60.
6. Nicaeus TE, Adamis AP, Rubin PAD, et al. Sucralfate and basic fibroblast growth factor promote endothelial cell proliferation around porous alloplastic implants in vitro. Ophthalmic Plast Reconstr Surg 1996;12:235-9.
7. Folkman J. Angiogenesis: initiation and modulation. In: Nicolson GL, Milas L, eds. Cancer invasion and metastasis: biologic and therapeutic aspects. New York: Raven Press, 1984.
8. Klagsbrun M, Vlodavsky I. Biosynthesis and storage of basic fibroblast growth factor (bFGF) by endothelial cells: implication for the mechanism of action of angiogenesis. In: Barbul A, Pines E, Caldwell M, Hunt TK, eds. Growth factors and other aspects of wound healing. Biological and clinical implications. New York: Alan R. Liss, 1988.
9. Marchesi VT. Inflammation and healing. In: Kissane JM, ed. Anderson's pathology. St Louis: C.V. Mosby, 1985.
10. BenEzra D. Neovasculogenic ability of prostaglandins, growth factors, and synthetic chemoattractants. Am J Ophthalmol 1978;86:455-61.
11. Dethlefsen SM, Shepro D, D'Amore PA. Arachidonic acid metabolites in bFGF-PDGF-, and serum-stimulated vascular cell growth. Exp Cell Res 1994;212:262-73.
12. Gonzalez EM, Adamis AP, Folkman J. Systemic administration of an angiogenesis inhibitor (AGM-1470), inhibits bFGF-induced corneal neovascularization [Abstract]. Invest Ophthalmol Vis Sci 1992;33(suppl):424.
13. Li WW, Grayson G, Folkman J. Sustained-release endotoxin. Invest Ophthalmol Vis Sci 1991;32:2906-11.
14. Szabo S, Vattay P, Scarbrough E. Role of vascular factors, including angiogenesis, in the mechanisms of action of sucralfate. Am J Med 1991;91(suppl 2A):158S-60S.
15. 3H-thymidine uptake in retinal venular and capillary endothelial cells in vivo. Invest Ophthalmol Vis Sci 1990;31:1238-43.
16. Knighton DR, Phillips GD, Fiegel VD. Wound healing angiogenesis: indirect stimulation by basic fibroblast growth factor. J Trauma 1990;30(suppl):s134-44.
17. Gospodarowicz D, Bialecki H, Thakral TK. The angiogenic activity of the fibroblast and epidermal growth factor. Exp Eye Res 1979;28:501-14.
18. Buntrock P, Jentzsch KD, Heder G. Stimulation of wound healing, using brian extract with fibroblast growth factor (FGF) activity. I. Quantitative and biochemical studies into formation of granulation tissue. Exp Pathol 1982;21: 46-53.
19. Buntrock P, Jentzsch KD, Heder G. Stimulation of wound healing, using brian extract with fibroblast growth factor (FGF) activity. II. Histological and morphometric examination of cells and capillaries. Exp Pathol 1982;21:62-7.
20. Davidson JM, Klagsbrun M, Hill KE, et al. Accelerated wound repair, cell proliferation, and collagen accumulation are produced by a cartilage-derived growth factor. J Cell Biol 1985;100:1219-27.
21. Sprugel KH, McPherson JM, Clowes AW, Ross R. Effects of growth factors in vivo: I. Cell ingrowth into porous subcutaneous chambers. Am J Pathol 1987;129:601-13.
22. McGee GS, Davidson JM, Buckley A, et al. Recombinant basic fibroblast growth factor accelerates wound healing. J Surg Res 1988;45:145-53.
23. Greenhalgh DG, Sprugel KH, Murray MJ, Ross R. PDGF and FGF stimulate wound healing in the genetically diabetic mouse. Am J Pathol 1990;136:1235-46.
24. Stenberg BD, Phillips LG, Hokanson JA, Heggers JP, Robson MC. Effect of bFGF on the inhibition of contraction caused by bacteria. J Surg Res 1991;50:47-50.
25. Grotendorst GR, Martin GR, Pencev D, Sodek J, Harvey AK. Stimulation of granulation tissue formation by platelet-derived growth factor in normal and diabetic rats. J Clin Invest 1985;76:2323-9.
26. Uhl E, Barker JH, Bondar I, et al. Basic fibroblast growth factor accelerates wound healing in chronically ischaemic tissue. Br J Surg 1993;80:977-80.
27. Kamler M, Lehr HA, Barker JH, Saetzler RK, Uhl E, Messmer K. Impact of basic fibroblast growth factor (bFGF) on wound healing in chronically ischemic tissue. In: Steiner R, Weisz PB, Langer R, eds. Angiogenesis: key principles, science, technology, medicine. Boston: Birkhauser Verlag, 1992.
28. Soubrane G, Jerdan J, Karpouzas I. Binding of basic fibrovascular growth factor to normal and neovascularized rabbit cornea. Invest Ophthalmol Vis Sci 1990;31:323-33.
29. Folkman J, Klagsbrun M, Sasse J, Wadzinski M, Ingber D, Vlodavsky I. A heparin-binding angiogenic protein - basic fibroblast growth factor - is stored within basement membrane. Am J Pathol 1988;130:393-400.
30. Folkman J, Szabo S, Shing Y. Sulcralfate affinity for fibroblast growth factor [Abstract]. J Cell Biol 1990;111: 223A.
31. Folkman J, Szabo S, Stovroff M. Duodenal ulcer: discovery of a new mechanism and development of angiogenic therapy that accelerates healing. Ann Surg 1991;214:414-25.
32. Szabo S. The mode of action of sucralfate: the 1 × 1 × 1 mechanism of action. Scand J Gastroenterol 1992; 185(suppl):7-12.
33. Langer R, Folkman J. Polymers for the sustained release of proteins and other macromolecules. Nature 1976;263: 797-800.
34. Roy DM, Linnehan SK. Hydroxyapatite formed from coral skeletal carbonate by hydrothermal exchange. Nature 1974;247:220-2.
35. Dutton JJ. Coralline hydroxyapatite as an ocular implant. Ophthalmology 1991;98:370-7.
36. Perry AC. Integrated orbital implants. Adv Ophthalmic Plast Reconstr Surg 1990;8:75-81.
37. Shanbhag A, Friedman III, Augustine J, von Recum AF. Evaluation of porous polyethylene for external ear reconstruction Ann Plast Surg 1990;24:32-9.
38. Kane PM, Duncavage JA, Thomas JH, Stageman DL, Toohill RJ. Alloplastic implants of the larynx. Arch Otolaryngol 1983;109:648-52.
39. Deeb ME, Roszkowski M, Hakim IE. Tissue response to hydroxyapatite in induced diabetic and nondiabetic rats: histologic evaluation. J Oral Maxillofac Surg 1990;48: 476-81.
40. Schrock TR, Deveney CW, Dunphy JE. Factors contributing to leakage of colonic anastomoses. Ann Surg 1973; 177:513-8.
41. Poole GV Jr. Mechanical factors of abdominal wound closure: The prevention of fascial dehiscence. Surgery 1985; 97:631-9.